Xiangxue Pharmaceutical Revenue

In the year 2025, Xiangxue Pharmaceutical had annual revenue of 1.60B CNY, down -14.16%. Xiangxue Pharmaceutical had revenue of 449.49M in the quarter ending December 31, 2025, with 38.26% growth.

Revenue

1.60B

Revenue Growth

-14.16%

P/S Ratio

3.90

Revenue / Employee

576.17K

Employees

2,769

Market Cap

6.22B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.60B	-263.25M	-14.16%
Dec 31, 2024	1.86B	-440.63M	-19.16%
Dec 31, 2023	2.30B	112.22M	5.13%
Jan 1, 2023	2.19B	-783.51M	-26.38%
Jan 1, 2022	2.97B	-101.51M	-3.30%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Innovita Biological Technology	422.03M
R&G PharmaStudies	851.01M
Shouyao Holdings (Beijing) Co., LTD.	34.67M
Lifecome Biochemistry	502.95M
Novogene	2.26B
Shenzhen Weiguang Biological Products	1.26B
Wuhan Keqian Biology Co.,Ltd	949.74M
PharmaResources (Shanghai)	667.47M

Revenue Rankings